The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications

Journal of Medical Screening

Volumn 24, Issue 4, 2017, Pages 220-222

  Doroudi, Maryam ^a   Kramer, Barnett S ^a   Pinsky, Paul F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bimanual ovarian palpation; Colorectal and ovarian cancer screening trial; Complications; Lung; Negative predictive value; Ovarian cancer; Positive predictive value; Prostate; Sensitivity; Specificity

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

AGED; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; ECHOGRAPHY; FALSE POSITIVE RESULT; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; OVARY TUMOR; PALPATION; PREDICTIVE VALUE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

AGED; BIOMARKERS, TUMOR; CA-125 ANTIGEN; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; PALPATION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 85042012153     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141316680381     Document Type: Article

References (9)

1. Final Research Plan for Gynecological Conditions: screening with the pelvic examination, www.uspreventiveservicestaskforce.org/Page/Document/finalresearch- plan137/gynecological-conditions-screening-with-the-pelvic-examination (accessed 23 June 2016).
2. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011; 305: 2295-2303.
3. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21: 273S-309S.
4. Weissfeld JL, Fagerstrom RM, O’Brien B, et al. Quality control of cancer screening examination procedures in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21: 390S-399S.
5. Adonakis GL, Paraskevaidis E, Tsiga S, et al. A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Biol 1996; 65: 221-225.
6. Jacobs I, Stabile I, Bridges J, et al. Multimodal approach to screening for ovarian cancer. Lancet 1988; 1: 268-271.
7. Grover S, Quinn MA, Weideman P, et al. Screening for ovarian cancer using serum CA125 and vaginal examination: report on 2550 females. Int J Gynecol Cancer 1995; 5: 291-295.
8. Siegel RL, Miller KD and Jemal A. Cancer statistics, 2016. CA:Cancer J Clin 2016; 66: 7-30.
9. Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 2016; 387: 945-956.